Pro Share Advisors LLC Beam Therapeutics Inc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 19,319 shares of BEAM stock, worth $488,577. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,319
Previous 15,072 28.18%
Holding current value
$488,577
Previous $353,000 33.99%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$22.57 - $33.14 $95,854 - $140,745
4,247 Added 28.18%
19,319 $473,000
Q2 2024

Aug 13, 2024
SELL
$21.22 - $32.66 $94,195 - $144,977
-4,439 Reduced 22.75%
15,072 $353,000
Q1 2024

May 08, 2024
BUY
$23.46 - $45.07 $43,940 - $84,416
1,873 Added 10.62%
19,511 $644,000
Q4 2023

Feb 14, 2024
BUY
$17.69 - $30.76 $60,128 - $104,553
3,399 Added 23.87%
17,638 $480,000
Q3 2023

Nov 13, 2023
BUY
$23.01 - $32.46 $9,641 - $13,600
419 Added 3.03%
14,239 $342,000
Q2 2023

Aug 10, 2023
BUY
$29.32 - $35.99 $25,801 - $31,671
880 Added 6.8%
13,820 $441,000
Q1 2023

May 11, 2023
SELL
$30.15 - $48.79 $59,124 - $95,677
-1,961 Reduced 13.16%
12,940 $396,000
Q4 2022

Feb 02, 2023
BUY
$36.73 - $51.6 $38,052 - $53,457
1,036 Added 7.47%
14,901 $582,000
Q3 2022

Nov 04, 2022
BUY
$39.79 - $70.31 $19,656 - $34,733
494 Added 3.69%
13,865 $661,000
Q2 2022

Aug 01, 2022
SELL
$29.86 - $62.36 $130,667 - $272,887
-4,376 Reduced 24.66%
13,371 $516,000
Q1 2022

May 10, 2022
SELL
$53.73 - $82.16 $223,301 - $341,456
-4,156 Reduced 18.97%
17,747 $1.02 Million
Q4 2021

Feb 08, 2022
BUY
$68.02 - $99.06 $20,678 - $30,114
304 Added 1.41%
21,903 $1.75 Million
Q3 2021

Nov 12, 2021
SELL
$84.37 - $133.6 $154,734 - $245,022
-1,834 Reduced 7.83%
21,599 $1.88 Million
Q2 2021

Aug 13, 2021
BUY
$64.12 - $128.71 $303,031 - $608,283
4,726 Added 25.26%
23,433 $3.02 Million
Q1 2021

May 14, 2021
BUY
$71.28 - $120.75 $65,577 - $111,090
920 Added 5.17%
18,707 $1.5 Million
Q4 2020

Feb 09, 2021
BUY
$22.24 - $95.63 $395,582 - $1.7 Million
17,787 New
17,787 $1.45 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email